Trump’s “America First” global health reset: what it means for AIDS, pandemics and US leadership

When Donald Trump’s administration unveiled its new “America First Global Health Strategy”, it signaled more than just a policy tweak. It marked a fundamental reset in how the United States plans to fund HIV, malaria and other disease programs overseas — and how it sees its role in the global health system.

Supporters argue the strategy will push partner countries to take greater responsibility for their own health systems. Critics warn it risks weakening hard-won progress against AIDS and other epidemics, while sidelining international institutions that have underpinned global health for decades.:contentReference[oaicite:0]{index=0}

From multilateral leadership to bilateral deals

For roughly 20 years, US global health efforts have been defined by large, multilateral initiatives like the Global Fund to Fight AIDS, Tuberculosis and Malaria and US-backed programs such as PEPFAR, which have helped save millions of lives. The new strategy keeps some of that funding in place but changes the way future money flows.:contentReference[oaicite:1]{index=1}

Instead of routing most support through international organizations and big NGOs, the Trump team is now prioritizing direct, country-by-country compacts. Under this model, Washington signs multi-year agreements with individual governments, tying US dollars to specific commitments from those countries on spending, data sharing and health reforms.

Kenya, Uganda and Rwanda as early test cases

Kenya became the first major test case when the US signed a five-year, roughly $1.6 billion health compact with Nairobi. In exchange, Kenya pledged to boost its own health budget by about $850 million, gradually taking over more of the costs for frontline workers and disease programs previously funded by foreign aid.

Uganda quickly followed, with a framework that could bring up to $1.7 billion in US support over five years for HIV, tuberculosis, malaria and maternal and child health, while Kampala committed to increase domestic health spending by around $500 million. Rwanda signed a smaller, but symbolically important, agreement worth roughly $228 million.

These deals illustrate the core logic of Trump’s approach: US money is still on the table, but future support is increasingly conditional on partners putting in more of their own cash and agreeing to a far more transactional relationship with Washington.

Aid cuts, USAID’s dismantling and the WHO exit

The new strategy does not exist in a vacuum. It comes on the heels of broader foreign aid cuts and the dismantling of the US Agency for International Development (USAID), which for years was the backbone of US global health programming.

At the same time, the United States is preparing to withdraw from the World Health Organization in early 2026, deepening the shift away from multilateral health institutions. Critics worry that walking away from the WHO and scaling back contributions to funds like the Global Fund could weaken surveillance for new disease threats, undermine vaccine campaigns and slow progress against HIV and TB in some of the world’s most vulnerable countries.

“Self-reliance” or shifting the burden?

Trump officials say the new framework is about fairness and sustainability. In their view, middle-income countries with growing economies should not rely indefinitely on American taxpayers to bankroll their health systems. The compacts build in co-financing targets and timelines by which governments are expected to assume more of the costs for medicines, health workers and clinics.

Health experts and advocates don’t dispute the importance of domestic investment, but they warn the pace and scale of the shift may be unrealistic. Many of the countries involved still face high debt loads, climate-driven disasters and fragile tax bases. If US support falls faster than domestic budgets can rise, programs that provide antiretroviral treatment, malaria bed nets or childhood vaccinations could be stretched thin or quietly scaled back.

Tensions with NGOs and questions over data access

The “America First” strategy also echoes long-standing political skepticism in Washington toward large international NGOs. Senior officials have openly criticized what they call the “NGO industrial complex” and argue that routing money through national governments will create clearer lines of accountability.

Yet civil society groups caution that bypassing experienced NGOs can weaken oversight and reach, particularly in rural or marginalized communities. They note that, in many countries, non-governmental clinics and community organizations have been the backbone of HIV testing and treatment, especially for key populations who may distrust government services.

Privacy advocates have raised another concern: provisions in some agreements that allow US agencies increased access to partner countries’ health data, including information related to potential pandemic pathogens. Kenyan critics, for instance, have pressed their government to clarify what types of data the US will receive and how it will be protected, even as officials insist records will be anonymized and subject to local law.

What’s at stake for the fight against AIDS and future pandemics

For people living with HIV and for countries still battling AIDS, TB and malaria, the stakes are concrete. US funding has helped drive down AIDS-related deaths, expand access to antiviral drugs and prevent mother-to-child transmission in much of sub-Saharan Africa. A mis-timed pullback, advocates say, could reverse some of that progress just as new generations are coming of age.

There is also a broader question of global preparedness. Successful pandemic response relies on early detection, strong laboratories and rapid information-sharing. If the US withdraws from multilateral platforms while its domestic public health agencies face political pressure at home, other countries and institutions may have to fill gaps in funding and coordination.

America’s new message to the world

The Trump administration is betting that its new strategy will be seen as a tough-minded but practical reset: fewer blank checks to international organizations, more direct contracts with governments and clearer demands that partner countries invest in their own systems.

For allies and critics alike, the message is unmistakable: the United States still wants to be a major player in global health, but on its own terms, with narrower priorities and sharper conditions. Whether that approach ultimately strengthens health systems — or leaves dangerous gaps in the global fight against AIDS and future pandemics — will become clearer as the first generation of “America First” health compacts plays out over the next few years.